Efficacy and safety of ormeloxifene in management of menorrhagia: A pilot study

Journal of Obstetrics and Gynaecology Research

Volumn 35, Issue 4, 2009, Pages 746-752

  Kriplani, Alka ^a   Kulshrestha, Vidushi ^a   Agarwal, Nutan ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Centchroman; Menorrhagia; Ormeloxifene

Indexed keywords

CENTCHROMAN; FENTICLOR; HEMOGLOBIN;

ABDOMINAL PAIN; ADULT; AMENORRHEA; ARTICLE; BLOOD VOLUME; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG WITHDRAWAL; DYSPEPSIA; FEMALE; FOLLOW UP; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN TISSUE; MENORRHAGIA; MENSTRUATION; OVARY CYST; PATIENT COMPLIANCE; SCORING SYSTEM; TREATMENT DURATION; TREATMENT RESPONSE; UTERINE CERVIX EROSION; VAGINA DISCHARGE; VISUAL ANALOG SCALE;

ADULT; BENZOPYRANS; ENDOMETRIUM; FEMALE; HEMOGLOBINS; HUMANS; MEDICATION ADHERENCE; MENORRHAGIA; PILOT PROJECTS; RECURRENCE; SELECTIVE ESTROGEN RECEPTOR MODULATORS; TIME FACTORS;

EID: 70049118501     PISSN: 13418076     EISSN: 14470756     Source Type: Journal    
DOI: 10.1111/j.1447-0756.2008.00987.x     Document Type: Article

References (26)

1. Monteiro I, Bahamondes L, Diaz J, Perrotti M, Petta C. Therapeutic use of levonorgestrel releasing intrauterine system in women with menorrhagia: A pilot study. Contraception 2002 65 : 325 328.
2. Higham JM, O'Brien PM, Shaw RW. Assessment of menstrual blood loss using a pictorial chart. Br J Obstet Gynaecol 1990 97 : 734 739.
3. Abbott JA, Garry R. The surgical management of menorrhagia. Hum Reprod Update 2002 8 : 68 78.
4. Liu DTY. Treatment of dysfunctional uterine bleeding. Amenorrhoea need not be an end point. BMJ 1995 310 : 802.
5. Scottish Hysteroscopy Audit Group. A Scottish audit of hysteroscopic surgery for menorrhagia: Complications and follow up. Br J Obstet Gynaecol 1995 102 : 249 254.
6. Lethaby A, Hickey M, Garry R. Endometrial destruction techniques for heavy menstrual bleeding. Cochrane Database Syst Rev 2005 4 CD001501.
7. Singh KC, Sengupta R, Agarwal N, Misra K. Thermal endometrial ablation: A simple technique. Acta Obstet Gynecol Scand 2000 79 : 54 59.
8. Dicker RC, Geenspan JR, Stauss LT et al. Complications of abdominal and vaginal hysterectomy among women of reproductive age in the United States. Am J Obstet Gynecol 1982 144 : 841 848.
9. Macdonald R. Modern treatment of menorrhagia. Br J Obstet Gynaecol 1990 97 : 3 7.
10. Munro MG. Medical management of abnormal uterine bleeding. Obstet Gynecol Clin North Am 2000 27 : 287 304.
11. Milsom I. The levonorgestrel-releasing intrauterine system as an alternative to hysterectomy in peri-menopausal women. Contraception 2007 75 : S152 S154.
12. Kriplani A, Singh BM, Lal S, Agarwal N. Efficacy, acceptability and side effects of the levonorgestrel intrauterine system for menorrhagia. Int J Gynecol Obstet 2007 97 : 190 194.
13. Ray S, Grover PK, Kamboj VP, Setty BS, Kar AB, Anand N. Antifertility agents, structure activity relationship of 3,4-diphenyl chromenes and chromans. J Med Chem 1976 19 : 276 279.
14. Singh MM. Centchroman, a selective estrogen receptor modulator, as a contraceptive and for the management of hormone- related clinical disorders. Med Res Rev 2001 21 : 303 347.
15. Misra NC, Nigam PK, Gupta R, Agarwal AK, Kamboj VP. Centchroman: A non-steroidal anticancer agent for advanced breast cancer: Phase II study. Int J Cancer 1989 43 : 781 783.
16. Sankaran MS, Prasad MRN. Mode of action of a new non-steroidal post-coital antifertility agent (centchroman: 67/20 CDRI) in rats. Contraception 1974 9 : 279 289.
17. Singh MM, Kamboj VP, Kar AB. Effect of intravaginal instillation of some non-steroidal oral antifertility agents on pregnancy in rats. Indian J Exp Biol 1974 12 : 370 371.
18. Farquhar CM. Management of dysfunctional uterine bleeding. Drugs 1992 44 : 578 584.
19. Lal J, Asthana OP, Nityanand S, Gupta RC. Pharmacokinetics of centchroman in healthy female subjects after oral administration. Contraception 1995 52 : 297 300.
20. Lal J, Nityanand S, Asthana OP, Nelamangala VN, Gupta RC. Optimization of contraceptive dosage regimen of centchroman. Contraception 2001 63 : 47 51.
21. Palomba S, Orio F Jr., Russo T et al. Antiproliferative and proapoptotic effects of raloxifene on uterine leiomyomas in postmenopausal women. Fertil Steril 2005 84 : 154 161.
22. Palomba S, Orio F Jr., Morelli M et al. Raloxifene administration in premenopausal women with leiomyomas: A pilot study. J Clin Endocrinol Metab 2002 87 : 3603 3608.
23. Bonnar J, Sheppard BL. Treatment of menorrhagia during menstruation: Randomized controlled trial of ethamsylate, mefenemic acid and tranexamic acid. BMJ 1996 313 : 579 582.
24. Milsom I, Andersson K, Andersch B, Rybo G. A comparison of flurbiprofen, tranexamic acid and a levonorgestrel releasing intrauterine contraceptive device in the treatment of idiopathic menorrhagia. Am J Obstet Gynecol 1991 164 : 879 883.
25. Rajan R. Contraceptive and non contraceptive benefits of centchroman. Asian J Obstet Gynecol Practice 1996 1 : 65 71.
26. Rajan R. Contraceptive and non-contraceptive benefits of centchroman. In : Rajan R (ed.). Reproductive Endocrinology. New Delhi : Jaypee Brothers, 1997 487 497.